Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/1/2024 | Buy → Neutral | BTIG Research | |
7/20/2022 | $2.50 | Equal-Weight | Morgan Stanley |
2/11/2022 | $4.50 | Neutral | Goldman |
2/11/2022 | Neutral | Goldman Sachs | |
8/4/2021 | $11.00 | Buy | Canaccord Genuity |
7/28/2021 | $15.00 | Buy | BTIG Research |
ATLANTA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it has won 17 Digital Health Awards in the Health Information Resource Center's Fall 2024 competition. Now in its 26th year, the semiannual Digital Health Awards honor the best online and virtual health resources for both consumers and professionals. "At Sharecare, our mission is to empower every individual to take control of their health and well-being, no matter where they are in their journey," said Dawn Whaley, president and chief marketing officer at Sharecare. "From our flagship platf
ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, announced today a slate of six new interactive media solutions designed to engage, educate, and activate patients and providers to better understand health conditions and take meaningful action towards improved health and well-being. The expansion of Sharecare's robust suite of customer activation and management solutions enables life sciences brands to align their marketing campaigns and health promotion efforts with the latest consumer insights and industry trends. Leveraging cutting-edge technology, i
ATLANTA and NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced the completion of its acquisition by Altaris, LLC (collectively with its managed funds, "Altaris"), an investment firm exclusively focused on the healthcare industry, for $1.43 per share in cash. The transaction was announced on June 21, 2024, and received approval from stockholders on October 17, 2024. As a result of the acquisition, Sharecare's common stock ceased trading and will no longer be listed on the Nasdaq stock market. "Sharecare's Board of Directors and shareholders
4 - Sharecare, Inc. (0001816233) (Issuer)
4 - Sharecare, Inc. (0001816233) (Issuer)
4 - Sharecare, Inc. (0001816233) (Issuer)
15-12G - Sharecare, Inc. (0001816233) (Filer)
8-K/A - Sharecare, Inc. (0001816233) (Filer)
S-8 POS - Sharecare, Inc. (0001816233) (Filer)
BTIG Research downgraded Sharecare from Buy to Neutral
Morgan Stanley initiated coverage of Sharecare with a rating of Equal-Weight and set a new price target of $2.50
Goldman initiated coverage of Sharecare with a rating of Neutral and set a new price target of $4.50
ATLANTA, Jan. 11, 2023 /PRNewswire/ -- Sharecare, Inc. (NASDAQ:SHCR) ("Sharecare"), the digital health company that helps people manage all their health in one place, has appointed healthcare industry veteran and retiring Centene Corporation executive Brent Layton to its board of directors and Audit Committee, effective today. Mr. Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with extensive expertise in creating, scaling, and operating business in a highly regulated environment. Currently serving as seni
ATLANTA, Oct. 20, 2021 /PRNewswire/ -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced that Evan Smith, CFA, has joined the company as senior vice president of finance and investor relations, reporting to Sharecare's president and chief financial officer, Justin Ferrero. With over 25 years of investor relations and investing experience in the healthcare sector, Smith is responsible for strategic planning and development of Sharecare's investor relations activities as well as supporting growth initiat
ATLANTA, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended June 30, 2024. "We began the second half of 2024 executing on our Enterprise channel strategy to expand into additional verticals with the successful launch of our new platform purpose-built for Medicaid to 750,000 members on July 1," said Brent Layton, CEO of Sharecare. "I am very enthusiastic about the opportunity to drive activation, engagement, and positive impact in these verticals at scale, leveraging our highly configurable digital capabilities, data, and services while continui
ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended March 31, 2024. "As we report first quarter earnings, we are thrilled that our purpose-built digital navigation platform for Medicaid is launching on July 1, 2024, to approximately 750,000 Medicaid members," said Brent Layton, CEO of Sharecare. "As we successfully expand into new markets leveraging our assets, we remain committed to providing measurable value to our customers and renewing long-term relationships while also growing revenue across our three divisions – and I want to reite
ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ:SHCR), the digital health company that helps people manage all their health in one place, today announced that it will report first quarter fiscal 2024 financial results on Thursday, May 9, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. EDT on the same day. Conference Call Details The conference call can be accessed by dialing (833) 636-1352 for U.S. participants, or (412) 902-4148 for international participants, and asking to be joined into the Sharecare call; or via live audio webcast, available online at https://investors.sharecare.com. A webcast rep
During the last three months, 4 analysts shared their evaluations of Sharecare (NASDAQ:SHCR), revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 1 0 0 0 0 3M Ago 0 0 1 0 0 In the assessment of 12-month price targets, analysts unveil insights for Sharecare, presenting an average target of $1.46, a high estimate of $2.00, and a low estimate of $1.00. A decline of 9.88% from the prior av
Morgan Stanley analyst Craig Hettenbach maintains Sharecare (NASDAQ:SHCR) with a Equal-Weight and raises the price target from $1 to $1.43.
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Friday. The Dow traded down 0.01% to 39,133.99 while the NASDAQ fell 0.21% to 17,683.49. The S&P 500 also fell, dropping, 0.19% to 5,462.56. Check This Out: Apple To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday Leading and Lagging SectorsCommunication services shares jumped by 0.7% on Friday. In trading on Friday, information technology shares fell by 0.6%. Top Headline Shares of FactSet Research Systems Inc (NYSE:FDS) gained around 3% on Friday after the company posted better-than-expected first-quarter earnings. FactSet Research reported third-quarter fiscal 20
SC 13D/A - Sharecare, Inc. (0001816233) (Subject)
SC 13D/A - Sharecare, Inc. (0001816233) (Subject)
SC 13G - Sharecare, Inc. (0001816233) (Subject)